MOLECULAR HLA TYPING-THE BRAVE NEW WORLD
PROSTAGLANDIN E1 PROTECTS AGAINST ISCHEMIA-REPERFUSION INJURY OF THE LIVER BY INHIBITION OF NEUTROPHIL ADHERENCE TO ENDOTHELIAL CELLS1
PREVENTION OF LATE RENAL CHANGES AFTER INITIAL ISCHEMIA/REPERFUSION INJURY BY BLOCKING EARLY SELECTIN BINDING1
COMBINATION THERAPY WITH CYCLOSPORINE AND INTERLEUKIN-4 OR INTERLEUKIN-10 PROLONGS SURVIVAL OF SYNGENEIC PANCREATIC ISLET GRAFTS IN NONOBESE DIABETIC MICE
ALLOANTIBODY- AND T CELL-MEDIATED IMMUNITY IN THE PATHOGENESIS OF TRANSPLANT ARTERIOSCLEROSIS
IN SITU GENE TRANSFER INTO RAT AUXILIARY LIVER TRANSPLANT1
ENGRAFTMENT OF HUMAN KIDNEY TISSUE IN RAT RADIATION CHIMERA
ENGRAFTMENT OF HUMAN KIDNEY TISSUE IN RAT RADIATION CHIMERA
INDUCTION OF TOLERANCE WITH NONDEPLETING ANTI-CD4 MONOCLONAL ANTIBODIES IS ASSOCIATED WITH DOWN-REGULATION OF TH2 CYTOKINES1
PERCUTANEOUS MANAGEMENT OF A BLADDER-DRAINED PANCREAS TRANSPLANT PSEUDOCYST BY A TRANSCYSTIC APPROACH
SOLITARY PANCREAS TRANSPLANTATION FOR NONUREMIC PATIENTS WITH LABILE INSULIN-DEPENDENT DIABETES MELLITUS1
LONG-TERM ALLOGRAFT ACCEPTANCE IN A PATIENT WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER
INFECTIVITY OF HEPATIC ALLOGRAFTS WITH ANTIBODIES TO HEPATITIS B VIRUS
CHOLIC ACID SYNTHESIS IS REDUCED IN PEDIATRIC LIVER RECIPIENTS DURING GRAFT DYSFUNCTION DUE TO ISCHEMIC INJURY AND ALLOGRAFT REJECTION1,2
HIGH PREVALENCE OF ANEMIA AFTER CARDIAC TRANSPLANTATION IN CHILDREN
EVIDENCE FOR ENGRAFTMENT OF HUMAN BONE MARROW CELLS IN NON-LETHALLY IRRADIATED BABOONS1
IMPROVED TECHNIQUE OF HETEROTOPIC CERVICAL HEART TRANSPLANTATION IN MICE1,2
INFECTION-ASSOCIATED MACROPHAGE ACTIVATION ACCELERATES CHRONIC RENAL ALLOGRAFT REJECTION IN RATS1
LIVING-RELATED INTESTINAL TRANSPLANTATION
ACUTE RESPIRATORY FAILURE AND PULMONARY FIBROSIS SECONDARY TO ADMINISTRATION OF MYCOPHENOLATE MOFETIL
IMPAIRMENT OF FIBRINOLYTIC POTENTIAL IN LONG-TERM STEROID TREATMENT AFTER HEART TRANSPLANTATION1
LONG-TERM GANCICLOVIR PROPHYLAXIS FOR SUCCESSFUL PREVENTION OF PRIMARY CYTOMEGALOVIRUS (CMV) DISEASE IN CMV-SERONEGATIVE LIVER TRANSPLANT RECIPIENTS WITH CMV-SEROPOSITIVE DONORS1
HLA ANTIBODY SCREENING
ADMINISTRATION OF OKT3 AS A TWO-HOUR INFUSION ATTENUATES FIRST-DOSE SIDE EFFECTS1
EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION
LIMITED T-CELL REPERTOIRE IN RENAL ALLOGRAFT AND ALLOGENEIC MELANOMA TRANSMITTED BY THE GRAFT1
ALOPECIA AS A CONSEQUENCE OF TACROLIMUS THERAPY IN RENAL TRANSPLANTATION?
APOPTOSIS IS THE MAIN MECHANISM OF CARDIOMYOCYTE DEATH IN THE HYPERACUTE REJECTION OF HEART XENO- AND ALLOGRAFTS
ANNOUNCEMENTS
ERRATUM